Hearing
Resources
Hearing loss after treatment for childhood cancer at the Childrens Oncology Group guidelines for survivors of childhood and adolescent cancer.
The Hearing Foundation of Canada
American Speech-Language Hearing Association:
Boystown National Research Hospital-Hearing Loss:
John Hopkins Medicine - Hearing:
Hearing Aid Subsidies Across Canada
References
1. Ondrey FG et al. Radiation dose to otological structures during head and neck cancer radiation therapy.
2. Wallace WHB and Green DM. (2004) Late effects of childhood cancer. (pp 49-53) London, England: Arnold.
3. Schwartz CL, Hobbie WL, Constine LS, et al. (2005) Survivors of Childhood and Adolescent Cancer. (pp 95-123) . Heidelberg, Germany: Springer.
4. Grewal S, Merchant T, Raymond R et al. Auditory Late Effects of Childhood Cancer Therapy Group: A report from the Children's Oncology Group. J. Pediatr 2010:125:e938-e950
5. Schell MJ, McHaney VA, Green AA et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 1989:7(6):754-760
6. Merchant TE, Gould GJ, Xiong X et al. Early neuro-otologic effects of three dimensional irradiation in children with primary brain tumours. Int J Radiat Oncol Biol Phys 2004:58(4):1194-1207
7. Nakai Y, Konishi Y, Chang KC, et al. Ototoxicity of the anticancer drug cisplatin: an experimental study. Acta Otolaryngol 1982:93:227-232
8. Littman T, Magruder A, Strother D. Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study. J Am Acad Audiol 1998:9:257-262
9. Allen G, Tiu C, Koike K, et al. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy. Otolaryngol Head Neck Surg 1998:118:584-588
10. Berlin C, Hood L, Hurley A, et al. Hearing aids: only for hearing impaired patients with abnormal otoacoustic emissions. In: Berlin Cl (ed.) Hair cells and hearing aids. San Diego: Singular Publishing Group 1996.
11. Kemp G, Rose P, Lurain J et al. Amifostine pretreatement for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin oncol 1996:14:2101-2112
12. Schuchter L, Glick J. The current status of WR-2721(Amifostine) a chemotherapy and radiation therapy protector. Biol Ther Cancer 1993:3:1-10
13. Glover D, Riley L, Carmichael K, et al. Hypocalemia and inhibition of parathyroid hormone secretion after adminstration of WR-2721 (Amifostine) (a radioprotective and chemoprotective agent). N Engl J Med 1983:309:1137-1141
14. Hall JW (2000) Handbook of Otoacoustic emissions. Singular, San Diego.
15.Schell MJ, McHaney VA, Green AA et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 7:754-760
16. Gratton MA, Salvi RJ, Kamen BA et al. Interaction of cisplatin and noise on the peripheral auditory system. Hear Res. 50:211-223
17. Roland JT, Cohen NL. Vestibular and auditory ototoxicity. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE, Richardson MA (eds) Otolaryngology head and neck surgery, 3rd Edn. Mosby, St.Louis, pp3186-3197
18. Rybak LP Ototoxicity of loop diuretics. Otolaryngol Clin North Am 26:829-844
19. Bates DE, Beaumont SJ, Baylis BW. Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother 36:446-451
20. Stringer SP, Meyerhoff WL, Wright CG. Ototoxicity. In:Paparella MM, Shumrick DA (eds) Otolaryngology, 3rd edn. Saunders, Philadelphia, pp 1653-1669
21. Bhandare N, Antonelli PJ, Morris CG et al. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 2007:67(2):469-479
22. Kushner BH, Budnick A, Kramer K, et al. Ototoxicity from high dose use of platinum compounds in patients with neuroblastoma. Cancer. 2006:107(2):417-422
23. Dean JB, Hayashi SS, Albert CM, et al. Hearing loss in Pediatric Oncology Patients Receiving Carboplatin-containing Regimens. J Pediatr Heamtol Oncol 2008:30:130-140.
24. Bess F, Dodd-Murphy J, Parker R. Children with minimal senorineural hearing loss: prevalence, educational performance and functional status. Ear Hear. 1998:19:339-354
25. Kolinsky DC, Hayashi SS, Karzon R, et al. Late Onset Hearing Loss: A Significant Complication of Cancer Survivors Treated with Cisplatin Containing Chemotherapy Regiments. J Pediatri Hematol Oncol 2010:32:119-123
26. Neuwelt EA, Gilmer-Knight K, Lacy C et al. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain barrier disruption. Pediatr Blood Cancer. 2006:47(2):174-182
27. Mudd PA et al. Inner Ear, Ototoxicity. http://emedicine.medscape.com/article/857679-overview. Modified July 1 2010.
